SCHEMBL4781528

SCHEMBL4781528

CN1CCC(C(=O)N(C)C2CCCCC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.47
BRD4 O60885 1/20 0.42
GFER P55789 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.41
PKM P14618 2/20 0.41
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
DPP4 P27487 1/20 0.37
KCNH2 Q12809 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20096230 1.00 CCR5 (0.47) CCR5BRD4GFERNPC1RAB9A
SCHEMBL20096210 1.00 CCR5 (0.47) CCR5BRD4GFERNPC1RAB9A
SCHEMBL27324190 0.91 CCR5 (0.41) CCR5BRD4ALDH1A1PKMDPP4
SCHEMBL20095805 0.88 CCR5 (0.47) CCR5GFERNPC1RAB9AKMT2A
SCHEMBL27324191 0.82 PKM (0.36) CCR5BRD4PKMDPP4KCNH2
SCHEMBL18346747 0.81 CCR5 (0.53) CCR5GFERKMT2AALDH1A1PKM
SCHEMBL13817646 0.80 CCR5 (0.46) CCR5BRD4GFERKMT2AALDH1A1
SCHEMBL2743218 0.78 BCHE (0.47) KMT2AALDH1A1PKMDPP4BCHE
SCHEMBL14155735 0.78 BCHE (0.47) KMT2AALDH1A1PKMDPP4BCHE
SCHEMBL12225732 0.78 BCHE (0.47) KMT2AALDH1A1PKMDPP4BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008045564-A2 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE CHEMOKINE CCR2 RECEPTOR EPIX DELAWARE, INC. (US) 2008-04-17 WO claimed
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 WO disclosed